PRO-DEX INC (PDEX) Fundamental Analysis & Valuation

NASDAQ:PDEX • US74265M2052

Current stock price

49 USD
+0.03 (+0.06%)
Last:

This PDEX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. PDEX Profitability Analysis

1.1 Basic Checks

  • PDEX had positive earnings in the past year.
  • In the past year PDEX has reported a negative cash flow from operations.
  • Each year in the past 5 years PDEX has been profitable.
  • The reported operating cash flow has been mixed in the past 5 years: PDEX reported negative operating cash flow in multiple years.
PDEX Yearly Net Income VS EBIT VS OCF VS FCFPDEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M -10M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 17.41%, PDEX belongs to the top of the industry, outperforming 96.74% of the companies in the same industry.
  • The Return On Equity of PDEX (26.96%) is better than 96.74% of its industry peers.
  • The Return On Invested Capital of PDEX (16.51%) is better than 95.11% of its industry peers.
  • PDEX had an Average Return On Invested Capital over the past 3 years of 14.16%. This is above the industry average of 9.18%.
  • The 3 year average ROIC (14.16%) for PDEX is below the current ROIC(16.51%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 17.41%
ROE 26.96%
ROIC 16.51%
ROA(3y)10.79%
ROA(5y)11.4%
ROE(3y)17.93%
ROE(5y)20.5%
ROIC(3y)14.16%
ROIC(5y)12.68%
PDEX Yearly ROA, ROE, ROICPDEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • With an excellent Profit Margin value of 15.94%, PDEX belongs to the best of the industry, outperforming 91.85% of the companies in the same industry.
  • PDEX's Profit Margin has declined in the last couple of years.
  • The Operating Margin of PDEX (15.36%) is better than 82.61% of its industry peers.
  • PDEX's Operating Margin has declined in the last couple of years.
  • PDEX has a Gross Margin of 28.09%. This is in the lower half of the industry: PDEX underperforms 77.17% of its industry peers.
  • PDEX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 15.36%
PM (TTM) 15.94%
GM 28.09%
OM growth 3Y9.36%
OM growth 5Y-4.56%
PM growth 3Y7.44%
PM growth 5Y-5.13%
GM growth 3Y-2.11%
GM growth 5Y-4.93%
PDEX Yearly Profit, Operating, Gross MarginsPDEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. PDEX Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), PDEX is creating some value.
  • PDEX has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, PDEX has less shares outstanding
  • The debt/assets ratio for PDEX is higher compared to a year ago.
PDEX Yearly Shares OutstandingPDEX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M
PDEX Yearly Total Debt VS Total AssetsPDEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • PDEX has an Altman-Z score of 7.36. This indicates that PDEX is financially healthy and has little risk of bankruptcy at the moment.
  • PDEX has a better Altman-Z score (7.36) than 85.33% of its industry peers.
  • A Debt/Equity ratio of 0.21 indicates that PDEX is not too dependend on debt financing.
  • PDEX has a Debt to Equity ratio (0.21) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 7.36
ROIC/WACC1.64
WACC10.07%
PDEX Yearly LT Debt VS Equity VS FCFPDEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M 30M

2.3 Liquidity

  • PDEX has a Current Ratio of 3.73. This indicates that PDEX is financially healthy and has no problem in meeting its short term obligations.
  • PDEX has a Current ratio of 3.73. This is in the better half of the industry: PDEX outperforms 63.59% of its industry peers.
  • PDEX has a Quick Ratio of 2.14. This indicates that PDEX is financially healthy and has no problem in meeting its short term obligations.
  • With a Quick ratio value of 2.14, PDEX perfoms like the industry average, outperforming 54.89% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.73
Quick Ratio 2.14
PDEX Yearly Current Assets VS Current LiabilitesPDEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. PDEX Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 61.19% over the past year.
  • Measured over the past years, PDEX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.96% on average per year.
  • Looking at the last year, PDEX shows a very strong growth in Revenue. The Revenue has grown by 23.68%.
  • The Revenue has been growing by 13.84% on average over the past years. This is quite good.
EPS 1Y (TTM)61.19%
EPS 3Y35.1%
EPS 5Y10.96%
EPS Q2Q%8.2%
Revenue 1Y (TTM)23.68%
Revenue growth 3Y16.57%
Revenue growth 5Y13.84%
Sales Q2Q%11.12%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-4.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.48%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PDEX Yearly Revenue VS EstimatesPDEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
PDEX Yearly EPS VS EstimatesPDEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

4

4. PDEX Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 15.12 indicates a correct valuation of PDEX.
  • Compared to the rest of the industry, the Price/Earnings ratio of PDEX indicates a rather cheap valuation: PDEX is cheaper than 86.96% of the companies listed in the same industry.
  • PDEX's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.73.
  • With a Price/Forward Earnings ratio of 20.18, PDEX is valued on the expensive side.
  • Based on the Price/Forward Earnings ratio, PDEX is valued a bit cheaper than the industry average as 76.09% of the companies are valued more expensively.
  • PDEX is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.72, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.12
Fwd PE 20.18
PDEX Price Earnings VS Forward Price EarningsPDEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • PDEX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. PDEX is cheaper than 85.87% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.46
PDEX Per share dataPDEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The decent profitability rating of PDEX may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.38
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PDEX Dividend Analysis

5.1 Amount

  • PDEX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PDEX Fundamentals: All Metrics, Ratios and Statistics

PRO-DEX INC

NASDAQ:PDEX (3/19/2026, 8:22:47 PM)

49

+0.03 (+0.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-29
Earnings (Next)04-29
Inst Owners32.13%
Inst Owner Change-6.03%
Ins Owners36.66%
Ins Owner Change1.64%
Market Cap157.29M
Revenue(TTM)66.59M
Net Income(TTM)11.19M
Analysts82.86
Price Target57.12 (16.57%)
Short Float %11.5%
Short Ratio8.8
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)74.8%
Min EPS beat(2)-24.91%
Max EPS beat(2)174.51%
EPS beat(4)3
Avg EPS beat(4)69.51%
Min EPS beat(4)-24.91%
Max EPS beat(4)174.51%
EPS beat(8)5
Avg EPS beat(8)44.11%
EPS beat(12)7
Avg EPS beat(12)20.2%
EPS beat(16)8
Avg EPS beat(16)16.17%
Revenue beat(2)1
Avg Revenue beat(2)7.28%
Min Revenue beat(2)-4.18%
Max Revenue beat(2)18.74%
Revenue beat(4)2
Avg Revenue beat(4)7.58%
Min Revenue beat(4)-4.18%
Max Revenue beat(4)19.3%
Revenue beat(8)6
Avg Revenue beat(8)12.93%
Revenue beat(12)9
Avg Revenue beat(12)11.32%
Revenue beat(16)12
Avg Revenue beat(16)11.48%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 15.12
Fwd PE 20.18
P/S 2.24
P/FCF N/A
P/OCF N/A
P/B 3.79
P/tB 3.79
EV/EBITDA 12.46
EPS(TTM)3.24
EY6.61%
EPS(NY)2.43
Fwd EY4.95%
FCF(TTM)-0.68
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS21.88
BVpS12.93
TBVpS12.93
PEG (NY)N/A
PEG (5Y)1.38
Graham Number30.7
Profitability
Industry RankSector Rank
ROA 17.41%
ROE 26.96%
ROCE 21.27%
ROIC 16.51%
ROICexc 20.85%
ROICexgc 20.86%
OM 15.36%
PM (TTM) 15.94%
GM 28.09%
FCFM N/A
ROA(3y)10.79%
ROA(5y)11.4%
ROE(3y)17.93%
ROE(5y)20.5%
ROIC(3y)14.16%
ROIC(5y)12.68%
ROICexc(3y)16.6%
ROICexc(5y)14.6%
ROICexgc(3y)16.62%
ROICexgc(5y)14.63%
ROCE(3y)18.25%
ROCE(5y)16.34%
ROICexgc growth 3Y23.73%
ROICexgc growth 5Y-8.41%
ROICexc growth 3Y23.84%
ROICexc growth 5Y-8.25%
OM growth 3Y9.36%
OM growth 5Y-4.56%
PM growth 3Y7.44%
PM growth 5Y-5.13%
GM growth 3Y-2.11%
GM growth 5Y-4.93%
F-Score6
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA 0.72
Cap/Depr 73.12%
Cap/Sales 1.3%
Interest Coverage 12.57
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.73
Quick Ratio 2.14
Altman-Z 7.36
F-Score6
WACC10.07%
ROIC/WACC1.64
Cap/Depr(3y)99.37%
Cap/Depr(5y)344.26%
Cap/Sales(3y)1.93%
Cap/Sales(5y)6.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.19%
EPS 3Y35.1%
EPS 5Y10.96%
EPS Q2Q%8.2%
EPS Next Y-4.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.68%
Revenue growth 3Y16.57%
Revenue growth 5Y13.84%
Sales Q2Q%11.12%
Revenue Next Year4.48%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.16%
EBIT growth 3Y27.48%
EBIT growth 5Y8.65%
EBIT Next Year10.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-206.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-142.63%
OCF growth 3YN/A
OCF growth 5YN/A

PRO-DEX INC / PDEX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for PRO-DEX INC?

ChartMill assigns a fundamental rating of 5 / 10 to PDEX.


What is the valuation status for PDEX stock?

ChartMill assigns a valuation rating of 4 / 10 to PRO-DEX INC (PDEX). This can be considered as Fairly Valued.


Can you provide the profitability details for PRO-DEX INC?

PRO-DEX INC (PDEX) has a profitability rating of 6 / 10.


What is the financial health of PRO-DEX INC (PDEX) stock?

The financial health rating of PRO-DEX INC (PDEX) is 6 / 10.


What is the expected EPS growth for PRO-DEX INC (PDEX) stock?

The Earnings per Share (EPS) of PRO-DEX INC (PDEX) is expected to decline by -4.43% in the next year.